News

IDx, a privately-held AI diagnostics company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company’s De Novo request to market IDx-DR, an AI-based diagnostic system for the autonomous detection of diabetic retinopathy, a leading cause of blindness. IDx-DR is the...
University of Iowa Department of Ophthalmology and Visual Sciences Presentations and Posters at ARVO 2018 Download PDF version Sunday, April 29 8:15 AM - 10 AM. Andreas Christian Borta, Oliver W. Gramlich , Kimberly Miller, Cheyanne Godwin, Remko Bakker, Markus H. Kuehn . Elevated Expression of...
Glaucoma specialist Dr. Nathan Sears was selected to receive the American Glaucoma Society’s 2018 Young Clinician Scientist Research Grant. Sears will use the grant funds to develop a new animal model of glaucoma to facilitate studies of the causes and cures for this potentially blinding disease...
Cataract is the leading cause of reversible vision loss and Glaucoma is the leading cause of permanent vision loss worldwide. Millions of people are impacted and unnecessarily blinded by these conditions each year – much of this taking place in low and middle-income countries. University of Iowa...
Publications from the past few weeks published by our faculty, residents, and fellows.
Iowa KidSight reached a milestone this week of extending vision screenings to over 500,000 children! Also noteworthy is that 29,328 (5.87%) of those children have required referral to an eye doctor. Four-and-a-half-year-old Maylee Rose Allen received the milestone screening. A celebration is being...
The 2017 Fall-2018 Winter issue of Iowa Vision is available here !